Pyrimidones for Treatment of Potassium Channel Related Diseases
申请人:Sakurada Isao
公开号:US20130184294A1
公开(公告)日:2013-07-18
The present invention relates to compounds of Formula I as described herein or a pharmaceutically acceptable salt thereof, pharmaceutical composition comprising a compound of Formula I or a pharmaceutically acceptable salt thereof and methods of treating a disease, disorder, or condition of the central nervous system, including bipolar disorder, depressive disorders, anxiety disorders, cognitive disorders, pain disorders, urogenital disorders, and epilepsy, among the other diseases, disorders or conditions discussed herein as mono-therapy or in combination with another active pharmaceutical ingredient.
ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND
申请人:Samsung Electronics Co., Ltd.
公开号:EP3461830A1
公开(公告)日:2019-04-03
An organometallic compound represented by Formula 1:
wherein, in Formula 1, groups and variables are the same as described in the specification.